Educational role of cancer pain rounds

1989 ◽  
Vol 4 (2) ◽  
pp. 113-116 ◽  
Author(s):  
David Weissman ◽  
Stephen Abram ◽  
J. David Haddox ◽  
Nora Janjan ◽  
Margaret Hopwood ◽  
...  
Keyword(s):  
2017 ◽  
Vol 12 (3) ◽  
pp. 155-162 ◽  
Author(s):  
Raffaele Giusti ◽  
Paolo Bossi ◽  
Marco Mazzotta ◽  
Marco Filetti ◽  
Daniela Iacono ◽  
...  

Background: Head and neck (H&N) cancers account for about 5% of all malignant tumours. Pain is one of the most feared consequences of H&N neoplasms and is experienced by up to 80% of patients and worsens their quality of life inhibiting speaking, eating, drinking or swallowing. Nevertheless, pain is still often underestimated and undertreated. Objectives: The role of opioids in cancer pain has been well established but evidences about the role and the relative effectiveness of opioids such as fentanyl in the context of H&N cancer pain remains unclear. Methods: A literature review based on the guidance of the Centre for Reviews and Dissemination was conducted. An iterative approach was used starting with an electronic search in the MEDLINE database. The search terms ((‘Neoplasms’[Mesh]) AND ‘Head and Neck Neoplasms’[Mesh]) AND ‘Fentanyl’[Mesh] were used. Results: A total of 18 publications were found by the first performed search on PubMed. Other publications concordant with our aim were found by cross-reference. Considering inclusion and exclusion criteria for our review, eight papers resulted eligible for analysis. Conclusion: Fentanyl transdermal therapeutic system (TTS) seems to be an important option, thanks to the way of administration, the good safety and tolerability profiles to control baseline pain. For breakthrough cancer pain (BTcP), several formulations of transmucosal fentanyl are available. All the formulations seem to be active and safety but we lack head-to-head studies of fentanyl versus other strong opioids, as well as with different formulation of fentanyl, particularly for BTcP where H&N cancer population is very poorly represented.


2010 ◽  
Vol 14 (5) ◽  
pp. 496-502 ◽  
Author(s):  
XiaoPing Gu ◽  
Juan Zhang ◽  
ZhengLiang Ma ◽  
JunHua Wang ◽  
XiaoFang Zhou ◽  
...  

1909 ◽  
Vol 9 (9-10) ◽  
pp. 471-486
Author(s):  
E M Idelson

One of the parental committees, which are now with us, at secondary educational institutions, with the aim of comprehensively clarifying the educational role of the transitional exams, invited many scientific societies, including our Society of Physicians, to express their opinion on this issue, from the point of view, specifically medical.


2015 ◽  
Vol 13 (2) ◽  
pp. 1220-1226 ◽  
Author(s):  
YAN YANG ◽  
JUAN ZHANG ◽  
YUE LIU ◽  
YAGUO ZHENG ◽  
JINHUA BO ◽  
...  

2020 ◽  
Vol 2020 ◽  
pp. 1-8
Author(s):  
Yinxia Wang ◽  
Ligang Xing

Radiotherapy is commonly used to treat cancer patients. Besides the curable effect, radiotherapy also could relieve the pain of cancer patients. However, cancer pain is gradually alleviated about two weeks after radiotherapy. In addition, cancer patients who receive radiotherapy may also suffer from pain flare or radiotherapy-induced side effects such as radiation esophagitis, enteritis, and mucositis. Pain control is reported to be inadequate during the whole course of radiotherapy (before, during, and after radiotherapy), and quality of life is seriously affected. Hence, radiotherapy is suggested to be combined with analgesic drugs in clinical guidelines. Previous studies have shown that radiotherapy combined with oxycodone hydrochloride can effectively alleviate cancer pain. In this review, we firstly presented the necessity of analgesia during the whole course of radiotherapy. We also sketched the role of oxycodone hydrochloride in radiotherapy of bone metastases and radiotherapy-induced oral mucositis. Finally, we concluded that oxycodone hydrochloride shows good efficacy and tolerance and could be used for pain management before, during, and after radiotherapy.


2015 ◽  
Vol 04 (14) ◽  
pp. 2418-2421
Author(s):  
Upendra Singh K ◽  
Kh. Lokeshwar Singh ◽  
Thoibahenba Singh S ◽  
Charan N ◽  
Jonan Puni Kay

Sign in / Sign up

Export Citation Format

Share Document